关注
Lucia Bailón
Lucia Bailón
Fundació Lluita contra les infeccions. Hospital Univesitari Germans Trias i Pujol, Badalona
在 flsida.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
C Suñer, M Ubals, EJ Tarín-Vicente, A Mendoza, A Alemany, ...
The Lancet Infectious Diseases 23 (4), 445-453, 2023
1102023
Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled …
K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ...
The Lancet Infectious Diseases 22 (12), 1703-1715, 2022
562022
Novel approaches towards a functional cure of HIV/AIDS
L Bailon, B Mothe, L Berman, C Brander
Drugs 80 (9), 859-868, 2020
432020
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
L Bailón, A Llano, S Cedeño, T Escribà, M Rosás-Umbert, M Parera, ...
Nature Medicine 28 (12), 2611-2621, 2022
322022
Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PWH with poor immune reconstitution
S Benet, O Blanch-Lombarte, E Ainsua-Enrich, N Pedreño-Lopez, ...
The Journal of infectious diseases 226 (11), 1913-1923, 2022
272022
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre …
J Corominas, C Garriga, A Prenafeta, A Moros, M Cañete, A Barreiro, ...
The Lancet Regional Health–Europe 28, 2023
252023
Estudio comparado de la diversidad florística en masas de origen natural y repoblado de Pinus sylvestris L. en la Sierra de Guadarrama (Sistema Central)
LJ Bailón, FM García, MC Tenerio
Forest Systems 15 (4), 111-123, 2008
92008
A placebo-controlled ATI trial of HTI vaccines in early treated HIV infection
L Bailon, A Llano, S Cedeño, MB Lopez, Y Alarcón‑Soto, P Coll
Retroviruses and Opportunistic Infections, Virtual, 2021
82021
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design
Á Bayón-Gil, MC Puertas, V Urrea, L Bailón, S Morón-López, P Cobarsí, ...
Journal of Antimicrobial Chemotherapy 75 (8), 2258-2263, 2020
82020
Altered T‐cell subset distribution in the viral reservoir in HIV‐1‐infected individuals with extremely low proviral DNA (LoViReTs)
C Gálvez, V Urrea, MC Garcia‐Guerrero, S Bernal, S Benet, B Mothe, ...
Journal of internal medicine 292 (2), 308-320, 2022
72022
Absence of drug–drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat
J Moltó, L Bailón, C Pérez-Mañá, E Papaseit, C Miranda, S Martín, ...
Journal of Antimicrobial Chemotherapy 77 (1), 181-184, 2022
52022
Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease
J Moltó, F Graterol, A Curran, N Ramos, A Imaz, D Sandoval, F Pérez, ...
Journal of Antimicrobial Chemotherapy 77 (7), 1989-1991, 2022
42022
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
J Corominas, C Garriga, A Prenafeta, A Moros, M Canete, A Barreiro, ...
medRxiv, 2024.02. 01.24302052, 2024
22024
Ambrisentan use in a HIV-1 infected patient with end-stage renal disease and pulmonary hypertension: minimal removal by hemodialysis-a case report
JR Santos, A Merino, WE Haefeli, C Miranda, M Prats, I Bancu, L Bailón, ...
BMC nephrology 21, 1-4, 2020
22020
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study
I Moraes-Cardoso, S Benet, J Carabelli, D Perez-Zsolt, A Mendoza, ...
The Lancet Microbe, 2024
12024
Early virological failure with cabotegravir/rilpivirine
L Bailón, S Sábato, J Coll, JR Santos, C Miranda, T Puig, A D´ Avolio, ...
Journal of Antimicrobial Chemotherapy 79 (5), 1193-1194, 2024
12024
Challenges of HIV therapeutic vaccines clinical trials design
L Bailon, Y Alarcón-Soto, S Benet
Current Opinion in HIV and AIDS 17 (6), 345-351, 2022
12022
Low viral reservoir treated individuals show unusual HIV latency distribution
C Gálvez, V Urrea, S Benet, B Mothe, L Bailón, J Dalmau, L Leal, F García, ...
12019
Prevalence of Anodyspareunia and its Impact on Daily Life in a Population of Men Who Have Receptive Anal Sex: an Observational Study
J Corral, C Gené-Škrabec, A Piqueras, L Bailón, C Suñer, E Gámez, ...
2024
A pre-post experimental study to assess the usefulness and feasibility of collecting routinely patient-reported outcomes in clinical practice (PROCARE)
C Iniesta, C Prats-Silvestre, MJ Galindo, A Ferrer, JC Lopez, L Perez, ...
HIV MEDICINE 24, 235-235, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20